Pleomorphic Xanthoastrocytoma Pediatric Research and Clinical Trials

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Glioma Program

We are the New England Phase I Center of the Children's Oncology Group. If your child has progressive or recurrent optic pathway gliomas, she may be eligible for a number of experimental therapies available through these groups, or from one of our independent clinical investigators.

What is the latest research on pleomorphic xanthoastrocytoma?

Boston Children's Hospital and Dana-Farber Cancer Institute are conducting numerous research studies that will help clinicians better understand and treat pleomorphic xanthoastrocytoma. For more information on current research, see the Brain Tumor Program.

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close